1792P Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors

Autor: Cuiffo, B., Maxwell, M., Yan, D., Rivest, B., Cardia, J., Fricker, S.P.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S1223-S1223
Databáze: ScienceDirect